statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Simulations Plus to Participate in KeyBancs 25th Annual Technology Leadership Forum

Simulations Plus, Inc. (Nasdaq: SLP) (Simulations Plus), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and medical communications for the biopharma...

Simulations Plus Announces New Research Project with the International Collaboration on Cosmetics Safety

Simulations Plus, Inc. (Nasdaq: SLP) (Simulations Plus), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma...

Simulations Plus Reports Third Quarter Fiscal 2024 Financial Results

Simulations Plus to Participate in the Morgan Stanley 3rd Annual Life Sciences AI Summit

Simulations Plus Announces Third Quarter Fiscal Year 2024 Earnings and Conference Call Date

Simulations Plus, Inc. (Nasdaq: SLP) (Simulations Plus), announced today that it will report third quarter fiscal 2024 financial results after the market close on Tuesday, July 2, 2024. Management...

QHP Capital-Backed Pro-ficiency Acquired by Simulations Plus

QHP Capital, L.P. (QHP), an investor in technology and services companies in the life sciences and healthcare sectors, today announced its sale of Pro-ficiency, LLC (Pro-ficiency or the Company), a...

Simulations Plus Acquires Pro-ficiency, Creating One-of-a-Kind Platform Spanning the Drug Development Continuum

Simulations Plus, Inc. (Nasdaq: SLP) (Simulations Plus), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced the acquisition of...

Simulations Plus to Participate in 21st Annual Craig-Hallum Institutional Investor Conference

Simulations Plus, Inc. (Nasdaq: SLP) (Simulations Plus), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today...

Simulations Plus Releases GastroPlus X, The Next Generation PBPK/PBBM Modeling & Simulation Software

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced the...

Simulations Plus (NASDAQ:SLP) Issues FY24 Earnings Guidance

Simulations Plus (NASDAQ:SLP - Get Free Report) issued an update on its FY24 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $0.66-0.68 for the...

Simulations Plus, Inc. provides modeling and simulation software and consulting services supporting drug discovery, development research and regulatory submissions. The firm operates through the Software and Services segment. It designs and develops pharmaceutical simulation software to promote cost-effective solutions to a number of problems in pharmaceutical research and in the education of pharmacy and medical students. The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered in Lancaster, CA.

Volume	101,448.00
52-Wk High	$52.69
52-Wk Low	$32.69

SLP Simulations Plus Inc.

About

Feed

News

Sentiment

Earnings

Fundamentals